• 1
    Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1996; 335: 15701580.
  • 2
    Van de Water J, Gershwin ME, Leung P, Ansari A, Coppel RL. The autoepitope of the 74-kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase. J Exp Med 1988; 167: 17911799.
  • 3
    Shimoda S, Nakamura M, Ishibashi H, Hayashida K, Niho Y. HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. J Exp Med 1995; 181: 18351845.
  • 4
    Kita H, Lian ZX, Van de Water J, He XS, Matsumura S, Kaplan M, Luketic V, et al. Identification of HLA-A2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells. J Exp Med 2002; 195: 113123.
  • 5
    Howard MJ, Fuller C, Broadhurst RW, Perham RN, Tang JG, Quinn J, Diamond AG, et al. Three-dimensional structure of the major autoantigen in primary biliary cirrhosis. Gastroenterology 1998; 115: 139146.
  • 6
    Bogdanos DP, Baum H, Vergani D. Antimitochondrial and other autoantibodies. Clin Liver Dis 2003; 7: 759777.
  • 7
    Haydon GH, Neuberger J. PBC: an infectious disease? Gut 2000; 47: 586588.
  • 8
    Joplin R. Thoughts on the infectious aetiology of primary biliary cirrhosis. In: MannsMP, PaumgartnerU, LeuschnerU, eds. Falk Symposium 114, Immunology and Liver. Dordrecht: Kluwer Academic Publishers, 2000: 268278.
  • 9
    Selmi C, Balkwill DL, Invernizzi P, Ansari A, Coppel R, Podda M, Leung P, et al. Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic metabolizing bacterium. HEPATOLOGY 2003; 38: 12501257.
  • 10
    Xu L, Sakalian M, Zhiwei S, Loss G, Neuberger J, Mason A. Cloning the human betaretrovirus proviral genome from patients with primary biliary cirrhosis. HEPATOLOGY 2004; 39: 151156.
  • 11
    Oldstone MB. Molecular mimicry and immune-mediated diseases. Faseb J 1998; 12: 12551265.
  • 12
    Bogdanos DP, Choudhuri K, Vergani D. Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences. Liver 2001; 21: 225232.
  • 13
    Burroughs AK, Butler P, Sternberg MJ, Baum H. Molecular mimicry in liver disease. Nature 1992; 358: 377378.
  • 14
    Shimoda S, Nakamura M, Shigematsu H, Tanimoto H, Gushima T, Gershwin ME, Ishibashi H. Mimicry peptides of human PDC-E2 163-176 peptide, the immunodominant T-cell epitope of primary biliary cirrhosis. HEPATOLOGY 2000; 31: 12121216.
  • 15
    Bogdanos DP, Baum H, Sharma UC, Grasso A, Ma Y, Burroughs AK, Vergani D. Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis. J Hepatol 2002; 36: 1421.
  • 16
    Sayers TJ, Baum H. Possible cross-reactivity of human anti-mitochondrial antibodies with membrane vesicles of Paracoccus denitrificans. Biochem Soc Trans 1976; 4: 138139.
  • 17
    Kita H, Matsumura S, He XS, Ansari AA, Lian ZX, Van de Water J, Coppel RL, et al. Analysis of TCR antagonism and molecular mimicry of an HLA-A0201-restricted CTL epitope in primary biliary cirrhosis. HEPATOLOGY 2002; 36: 918926.
  • 18
    Van de Water J, Ishibashi H, Coppel RL, Gershwin ME. Molecular mimicry and primary biliary cirrhosis: premises not promises. HEPATOLOGY 2001; 33: 771775.
  • 19
    Fussey SP, Lindsay JG, Fuller C, Perham RN, Dale S, James OF, Bassendine MF, et al. Autoantibodies in primary biliary cirrhosis: analysis of reactivity against eukaryotic and prokaryotic 2-oxo acid dehydrogenase complexes. HEPATOLOGY 1991; 13: 467474.
  • 20
    Shimoda S, Van de Water J, Ansari A, Nakamura M, Ishibashi H, Coppel RL, Lake J, et al. Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. J Clin Invest 1998; 102: 18311840.
  • 21
    Bogdanos DP, Baum H, Grasso A, Okamoto M, Butler P, Ma Y, Rigopoulou EI, et al. Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis. J Hepatol 2004; 40: 4351.
  • 22
    Bogdanos DP, Pares A, Sharma UC, Caballeria L, Ma Y, Burroughs AK, Rodes J, et al. Crossreactivity between mycobacterium gordonae and PDC-E2, the major target of antimitochondrial antibody, is present in Spanish but not British patients with primary biliary cirrhosis. J Hepatol 2001; 34( suppl): 19.
  • 23
    Bogdanos DP, Grasso A, Okamoto M, Montalto P, Butler P, Williams R, Burroughs AK, et al. Cross-reactivity to Lactobacillus delbrueckii/human pyruvate dehydrogenase complex-E2 characterizes primary biliary cirrhosis. HEPATOLOGY 2000; 32( suppl): 300A.
  • 24
    Selmi C, Mayo MJ, Bach N, Gish RG, Wright HI, Ishibashi H, et al. Occurrence of primary biliary cirrhosis in monozygotic twins. HEPATOLOGY 2002; 36( suppl): 387A.
  • 25
    Urnovitz HB, Murphy WH. Human endogenous retroviruses: nature, occurrence, and clinical implications in human disease. Clin Microbiol Rev 1996; 9: 7299.
  • 26
    Adelman MK, Marchalonis JJ. Endogenous retroviruses in systemic lupus erythematosus: candidate lupus viruses. Clin Immunol 2002; 102: 107116.
  • 27
    Mason AL, Xu L, Guo L, Munoz S, Jaspan JB, Bryer-Ash M, Cao Y, et al. Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet 1998; 351: 16201624.
  • 28
    Sadamoto T, Joplin R, Keogh A, Mason A, Carman W, Neuberger J. Expression of pyruvate-dehydrogenase complex PDC-E2 on biliary epithelial cells induced by lymph nodes from primary biliary cirrhosis. Lancet 1998; 352: 15951596.
  • 29
    Xu L, Shen Z, Guo L, Fodera B, Keogh A, Joplin R, O'Donnell B, et al. Does a betaretrovirus infection trigger primary biliary cirrhosis? Proc Natl Acad Sci U S A 2003; 100: 84548459.
  • 30
    Xu L, Guo L, Joplin R, Neuberger J, Rixon F, Aitkin J, Carman W, et al. Viral induction of primary biliary cirrhosis. J Hepatol 1997; 26( suppl 1): 61.
  • 31
    Wekerle H, Hohlfeld R. Molecular mimicry in multiple sclerosis. N Engl J Med 2003; 349: 185186.